Cough syrup row: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma drugs
Jaipur (PTI): The Rajasthan government has suspended the state drug controller and halted the distribution of medicines manufactured by Jaipur-based company Kaysons Pharma, officials said.
The Medical and Health Department stopped the supply of all 19 medicines manufactured by Kaysons Pharma until further orders, they said. Distribution of all other cough syrups containing Dextromethorphan has also been suspended.
The government has placed drug controller Rajaram Sharma under suspension for allegedly influencing the process of determining drug standards, the department said.
This comes amid reports of deaths of 11 children, nine in Madhya Pradesh and two in Rajasthan, allegedly linked to contaminated cough syrup.
Chief Minister Bhajanlal Sharma has ordered a detailed probe into the matter along with effective action.
Following his instructions, an expert committee is being constituted to investigate the issue.
Health Minister Gajendra Singh also ordered an inquiry and measures to safeguard public interest, an official statement said.
Principal Secretary in the Medical and Health Department, Gayatri Rathore, said the Union government issued an advisory in 2021 against administering Dextromethorphan to children below four years.
The state has reiterated the advisory, while the Drug Controller General of India on Friday advised that the syrup should normally be given only to children above five years, and in no circumstances to those under two years of age.
Officials added that drugs which are potentially harmful to children and pregnant women will now carry clear warning labels.
According to the managing director of Rajasthan Medical Services Corporation Ltd (RMSCL), Pukhraj Sen, over 10,000 samples of Kaysons Pharma drugs have been tested since 2012, of which 42 failed the quality standards.
As a precaution, the supply of all 19 medicines manufactured by the company has been suspended.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Rupee falls 11 paise to 94.27 against US dollar in early trade
Mumbai (PTI): The rupee depreciated 11 paise to 94.27 against US dollar in early trade on Monday driven by persistent dollar demand and a broader shift toward safe-haven assets.
Forex traders said the Indian rupee has hit a rough patch, falling for five consecutive sessions, weighed down by a combination of factors such as the RBI loosening its grip on currency rules and rising oil prices caused by global tensions.
Moreover, investors are becoming cautious again, with foreign institutions pulling money out of the market after a brief period of buying amid rising geopolitical uncertainty.
At the interbank foreign exchange market the rupee opened at 94.25 against the US dollar, then lost some ground and touched 94.27 against the US dollar in initial trade, registering a fall of 11 paise over its previous close. On Friday, the rupee had settled at 94.16 against the American currency.
ALSO READ: Death toll in Mundathikode fireworks explosion rises to 16
Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, was down 0.09 per cent at 98.44.
Brent crude, the global oil benchmark, was trading higher by 1.16 per cent at USD 106.55 per barrel in futures trade.
A mix of softer economic signals and renewed, even if fragile, hopes of diplomacy pulled the dollar lower again, CR Forex Advisors MD Amit Pabari said, adding that for Rupee, on one hand, a softer dollar offers relief. On the other, uncertainty remains the dominant force.
Meanwhile, India’s forex reserves have crossed USD 703 billion as of April 17, reflecting a consistent build-up of buffers.
"For now, the rupee continues to lean toward gradual weakness. Uncertainty remains the dominant force, shaping both global flows and local reactions," Pabari said.
He further noted that any dips are likely to be bought into, with the 92.80–93.20 zone acting as a strong support. On the upside, 93.50 to 94.50 is expected to define the near-term range.
On the domestic equity market front, the 30-share benchmark index Sensex was trading 518.96 points or 0.68 per cent higher at 77,183.17, while the broader Nifty was trading up 131.30 points or 0.55 per cent at 24,029.25.
Foreign Institutional Investors offloaded equities worth Rs 8,827.87 crore on Friday, according to exchange data.
